Skip to main content

Diabetes and Numbers


Hispanic, 43 year old female
Lots of stress in life
Diabetes for 2 years
Currently on Metformin 1000 mg BY MOUTH twice daily.

Clinic ran comprehensive metabolic panel.
Blood glucose 216, Hemoglobin A1C is 7.8

(ADA guideline: A1C of 6.5 or greater, confirmed diabetes with repeat)
High triglycerides and cholesterol.

Diabetes and numbers:

 American College of Physicians (ACP), in 2018 proposed changing the recommended A1C target guidelines.Based on outcomes and taking side effects and cost in to consideration they recommend patients with type 2 diabetes should aim to achieve an HbA1C between 7 and 8 percent instead of 6.5 to 7 percent, as previously advised by ADA. 

 The American Diabetes Association did not like the suggestions stating the old standard are better, saying that a “reasonable A1C goal for many non pregnant adults with Type 2 diabetes is less than 7 percent.

 We went with ADA guidelines and added Glyburide 5 mg daily with largest meal of the day Fenofibrate 145 mg daily with increase in activity/exercise and controlled diet.










Comments

  1. MaudMedicalApril 1, 2022 at 2:32 AM

    You have worked nicely with your insights that makes our work incontinence calgary. The information you have provided is really factual and significant for us. Keep sharing these types of article, Thank you.

    ReplyDelete
  2. ACA AdvisorJanuary 5, 2023 at 9:25 PM

    clearly, It is an engaging article for us which you have provided here about Best health insurance in Miami This is a great resource to enhance knowledge about it. Thank you.

    ReplyDelete

Post a Comment

Popular posts from this blog

Mounjaro, Is it a game changer for weight loss and diabetes?

  MOUNJARO™ ( Tirzepatide) was approved for medical use in the United States in May 2022 WEIGHT LOSS: (Not approved by FDA for weight loss) Eli Lilly and Company is  finalizing an application to the U.S. Food and Drug Administration for fast-track approval to sell tirzepatide for chronic weight management. MOUNJARO™ is a glucose-dependent insulinotropic polypeptide (GIP) receptor and glucagon-like peptide-1 (GLP-1) receptor agonist indicated in adults for type 2 diabetes mellitus management. CONTRAINDICATIONS Personal or family history of medullary thyroid carcinoma or in patients with Multiple Endocrine Neoplasia syndrome type 2  Known serious all to tirzepatide or any of the excipients in MOUNJARO                                                                    ...
Post a Comment
Read more

Thyroid health- Quality of Life

  Let's get a TSH blood test for our family and friends Normal serum TSH ranges are higher in the  people age 70 to 80 years ; based on this, higher serum TSH goals may be needed as a patient ages.  The American Thyroid Association (ATA) suggests raising the target serum TSH to 4-6 m IU/L for 70 years-old and up The thyroid is a small, butterfly-shaped hormone-producing gland located at the front of the neck. The thyroid gland secretes two main hormones:  thyroxine (T-4) and triiodothyronine (T-3).   These hormones regulate energy levels, metabolism of fats, proteins and carbohydrates, body temperature, heart rate.  Hypothyroidism happens when the underactive thyroid gland doesn't make enough hormones. Hypothyroidism affects up to 10% of the general population (5% undiagnosed) . A n autoimmune disease called Hashimoto's diseas e where our body  makes antibodies that attack healthy thyroid tissues  is the most common cause of hypothyroidism in soc...
Post a Comment
Read more

Vaccines, XBB.1.5 variant and antibody evasion

Corona virus XBB and XBB.1 were first identified in India in mid-August and quickly became predominant in India.  The spike protein of the predominant XBB subvariant has 14 mutations in addition to those found in BA.2, including 5 in the N-terminal domain (NTD) and 9 in the receptor-binding domain (RBD), whereas XBB.1 has an additional G252V mutation. Single and combination therapies with monoclonal antibodies have received emergency use authorization for COVID-19.  Using  COVID-19 pseudovirus, which enables the study of the SARS-CoV-2 virus in cell culture,   XBB, and XBB.1 subvariants were found to have far greater antibody resistance than earlier variants. XBB sublineages are completely resistant to bebtelovimab, leaving us with no authorized antibody for treatment use. The combination of mAbs known as Evusheld that is authorized for the prevention of COVID-19 is also completely inactive against the new subvariants. This poses a serious problem for millions of im...
Post a Comment
Read more